FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein ring A, R1-R8 and n are defined in the claims. New benzisoxazolesulfonamide derivatives could be used to treat abnormal cell growth, such as cancer, in patients.
EFFECT: combinations containing the compounds for treating cancer in a patient and a method of treating cancer are also provided.
30 cl, 1 dwg, 26 tbl, 128 ex
| Title | Year | Author | Number |
|---|---|---|---|
| N1/N2-LACTAM ACETYL-CoA-CARBOXYLASE INHIBITORS | 2011 |
|
RU2540337C2 |
| DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS SUITABLE AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | 2018 |
|
RU2804468C2 |
| COMPOUNDS | 2016 |
|
RU2725616C2 |
| 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 (IKZF2) OF THE IKAROS FAMILY | 2019 |
|
RU2797559C2 |
| SUBSTITUTED IMIDAZOPYRIDINYL-AMINO-PYRIDINE COMPOUNDS, USEFUL FOR TREATMENT OF CANCER | 2010 |
|
RU2619463C2 |
| ANTIBODY-DRUG CONJUGATE TARGETING TROP2, AND METHOD FOR PREPARING AND USING SAME | 2020 |
|
RU2822663C1 |
| PROTEIN-TYROSINPHOSPHATASE INHIBITORS AND METHODS OF THEIR USE | 2019 |
|
RU2799446C2 |
| CONJUGATE ANTIBODY-DERIVATIVE OF PYRROLOBENZODIAZEPINE | 2018 |
|
RU2820928C2 |
| NEW DERIVATIVES OF IMIDAZO [4,5-C] QUINOLINES AND IMIDAZO [4,5-C] [1,5] NAPHTHYRIDINES AS LRRK2 INHIBITORS | 2016 |
|
RU2722149C1 |
| HETEROCYCLIC COMPOUND | 2017 |
|
RU2748693C2 |
